First Trust Amex Biotech Index Fund (FBT): Price and Financial Metrics ETF
FBT Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $141.68 | 52-week high | $161.41 |
| Prev. close | $141.52 | 52-week low | $130.27 |
| Day low | $140.36 | Volume | 21,500 |
| Day high | $142.17 | Avg. volume | 28,900 |
| 50-day MA | $150.91 | Dividend yield | N/A |
| 200-day MA | $149.37 |
FBT Stock Price Chart Interactive Chart >
First Trust Amex Biotech Index Fund (FBT) ETF Bio
The investment objective of the First Trust Amex Biotech Index Fund ETF seeks to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.
FBT ETF Info
| Issuer | First Trust Portfolios |
| Expense Ratio | 0.55% |
| Underlying Index | NYSE Arca Biotechnology Index |
| Asset Class | Equity |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | 1.08B |
| Net Asset Value (NAV) | $141.60 |
| Options? | Yes |
| Total Holdings | 32 |
FBT Top Holdings
| Symbol | Company | % of Total |
| NTRA | Natera Inc. | 5.14% |
| BRKR | Bruker Corporation | 3.96% |
| HALO | Halozyme Therapeutics Inc. | 3.94% |
| ITCI | Intra-Cellular Therapies Inc. | 3.89% |
| UTHR | United Therapeutics Corporation | 3.88% |
| MTD | Mettler-Toledo International Inc. | 3.62% |
| NBIX | Neurocrine Biosciences Inc. | 3.6% |
| EXEL | Exelixis Inc. | 3.56% |
| CORT | Corcept Therapeutics Incorporated | 3.51% |
| BMRN | BioMarin Pharmaceutical Inc. | 3.46% |
FBT Price Returns
| 1-mo | -8.03% |
| 3-mo | -6.57% |
| 6-mo | 3.37% |
| 1-year | -10.29% |
| 3-year | -12.55% |
| 5-year | 5.25% |
| YTD | -10.36% |
| 2023 | 2.55% |
| 2022 | -4.83% |
| 2021 | -2.26% |
| 2020 | 12.96% |
| 2019 | 19.74% |